![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 31, 2014 10:07:29 AM
Existing antibacterials do two things to fight bacterial infections. First, they identify some molecule on the microorganism’s surface and bind to it. Once attached, they transport a drug into the bacterium to interfere with some critical part of its biological processes.
Bacteria, in turn, develop resistances by evolving the molecules being targeted by antibiotics so that the drugs can’t recognize or bind to their targets. They can also evolve their “efflux pumps” to expel the antibiotic drugs.
Welcome Defensins!
Found throughout the animal kingdom, including in insects, these natural biological antibiotics are called “defensins.” Structurally, defensins are peptides, short amino acid chains with an electrostatic charge. (Larger amino acid chains, by the way, are called proteins.)
Defensins attach themselves electrostatically to bacteria and other microorganisms, including fungi and some viruses. For targeted microbes, this attachment is the hug of death. Defensins lock onto bacteria and other microorganisms and effectively perforate their outer membranes. The resultant “leaks” disrupt the microorganisms’ vital functions.
This is one of the reason why bacteria don’t develop resistance to defensins. Whereas conventional antibiotics must penetrate bacterial cell walls, defensins act directly on the surface membrane. To escape the defensins, bacteria would have to evolve entirely new outer membrane characteristics, which is nearly inconceivable for these simple organisms.
This is from Patrick Cox newsletter back in January.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM